Multifactorial Etiologies of Chronic Pancreatitis-Induced Bone Loss

This section provides a comprehensive overview of bone loss in chronic pancreatitis (CP), emphasizing its high prevalence, clinical consequences, and multifactorial pathogenesis. It outlines CP as a progressive inflammatory disorder leading to irreversible pancreatic damage and exocrine/endocrine insufficiency, with systemic complications extending beyond the pancreas. Particular focus is placed on metabolic bone disease—encompassing osteopenia, osteoporosis, and fracture risk—which affects a significant proportion of CP patients. The discussion highlights three converging etiologic mechanisms underlying skeletal deterioration: (1) malabsorption-mediated nutritional deficiencies (notably vitamin D and K), (2) medication-induced bone loss (opioids, corticosteroids, proton pump inhibitors), and (3) metabolic and endocrine derangements including type 3c diabetes and chronic inflammation. The section underscores the clinical implications of osteosarcopenia, increased fracture-related morbidity and mortality, and the need for systematic screening and integrated management strategies. Overall, it frames CP-related bone disease as an underrecognized yet preventable complication requiring multidisciplinary attention and targeted research.